Evaluation of the 2023 Duke-ISCVID criteria in a multicenter cohort of patients with suspected infective endocarditis.

Matthaios Papadimitriou-OlivgerisPierre MonneyMichelle FrankGeorgios TzimasPiergiorgio TozziMatthias KirschMathias Van HemelrijckRobert BauernschmittJana EpprechtBenoit GueryBarbara Hasse

Published in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2024)

The Duke-ISCVID 2023 criteria led to an increase in sensitivity compared to previous versions. Further studies are needed to evaluate items that could increase sensitivity by reducing the number of IE patients misclassified as possible, but without having detrimental effect on specificity of Duke criteria.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
peritoneal dialysis
prognostic factors
clinical trial
patient reported outcomes
case control
patient reported